Xilinx Inc. announced unaudited consolidated earnings results for third quarter and nine months ended January 2, 2016. For the quarter, the company reported net revenues of $566,235,000, operating income of $160,104,000, income before income taxes of $155,051,000, net income of $130,819,000 or $0.49 per diluted share, net cash provided by operating activities was $290,285,000, purchases of property, plant and equipment of $6,118,000 compared to the net revenues of $593,549,000, operating income of $190,009,000, income before income taxes of $186,002,000, net income of $168,466,000 or $0.62 per diluted share, net cash provided by operating activities was $290,742,000, purchases of property, plant and equipment of $6,139,000 for the same quarter a year ago. Annual return on equity was 21% compared to 25% a year ago. Capital Expenditures was $6 million compared to $6 million a year ago.

For the nine months period, the company reported net revenues of $1,642,815,000 compared to $1,810,445,000 a year ago, operating income was of $491,781,000 compared to $596,558,000 a year ago, income before income taxes of $466,988,000 compared to $580,598,000 a year ago, net income of $405,833,000 or $1.51 per diluted share compared to $513,593,000 or $1.85 per diluted share a year ago, purchases of property, plant and equipment of $19,169,000 compared to $23,682,000 a year ago, net cash provided by operating activities was $607,168,000 compared to $624,741,000 a year ago.

The company provided earnings guidance for the quarter ending March 2016. For the quarter ending March 2015, the company sales are expected to be approximately flat sequentially. Gross margin is expected to be 68% to 69%. Operating expenses are expected to be approximately $220 million including $1 million of amortization of acquisition-related intangibles. Other income and expenses are expected to be a net expense of approximately $6 million. Fully diluted share count is expected to be approximately $267 million. March quarter tax rate is expected to be approximately 13-14%.